Clinical trial · Observational
Prospective Liver Study
Prospective Analysis of Liver Cancer Treatment and Interventions
NCT01539993CI-TRIAL-00014705completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This study is designed for patients diagnosed with Liver cancer to collect information about the relationship between types of liver cancer, methods of treatment and outcomes over time.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Liver Cancer | Malignant Liver Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (1)
- label
- 1
Primary outcomes (1)
- measure
- Assess efficacy of percutaneous and transarterial treatments for liver cancer.
- timeFrame
- 1 month
- description
- QOL questionnaire will be collected during follow up visit.
Secondary outcomes (1)
- measure
- long term follow up
- timeFrame
- 3 months, 6 months 1year
- description
- Patients will be administered QOL during 3 months, 6 months and 1 year follow up.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Patients diagnosed with Hepatocellular carcinoma and referred for percutaneous liver treatment. Exclusion Criteria: * Severe liver disfunction * Active uncontrolled infection * Significant underlying medical of physical illness
References
Publications (0)
Data not yet available
No reference posted for this study.